News

Information and Guidelines for Novel Coronavirus (COVID-19)


myMatrixx is closely monitoring the 2019 Novel Coronavirus (COVID-19) and our top priority is the safety and service of our customers, clients, employees and partners. “The spread of the novel coronavirus, COVID-19, is raising concerns around the world. People want to know how to stay safe, how to protect their loved ones, friends and colleagues …

2020 Updates for Drug Reference Guides


Our “Workers’ Compensation Pharmaceuticals: Prior Authorization and High Dollar Rejections Guide” and our “Brand to Generic Reference Guide: Workers’ Compensation Pharmaceuticals” are two of the most widely used reference materials at myMatrixx. Due to the constantly changing nature of the pharmaceuticals industry, it’s important to keep these guides updated regularly. Our team has recently released …

myMatrixx Leaders to Present at Upcoming RIMS Chapter Events


In a recent update, we shared that myMatrixx Clinical Account Executive Shanea McKinney has had multiple speaking proposals accepted to RIMS, the risk management society’s Professional Exchange of Risk Knowledge, or PERK, program. Well, we’re pleased to announce that two separate RIMS chapters have already selected the presentation, “Medical Marijuana’s Impact on Workers’ Comp” for …